Published on: July 28, 2025

India–UK FTA & Access to Medicines

The recently signed India–UK Free Trade Agreement has provisions that may undermine India’s ability to supply affordable medicines.

Key concerns:
⚠️ Preference for voluntary licenses over compulsory ones – limits price cuts
⚠️ Less transparency on patent working – harder to issue compulsory licenses
⚠️ Push for “harmonisation” – risk of evergreening & unnecessary patents

These changes tilt the balance in favour of big pharma and could hurt millions who rely on India’s generics.

Read the detailed press release below:

Let’s spread the word and stand up for our right to affordable medicines!